InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Pavliv Leo, Vice-Président Senior et Directeur du Développement. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Aggregated, 2 disclosures have been published. History available since 17 March 2021. The latest transaction was filed on 31 May 2022 (J). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pavliv Leo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
33,500 shares@ US$2.090.080% mcap80.8% of flowCommon StockSEC:0001209191-22-040113:0
2,870 shares@ US$3.2210.6% of flowCommon StockSEC:0001209191-21-039925:0
2 of 2 declarations
About Pavliv Leo
Leo Pavliv is Senior Vice President and Chief Development Officer at Cumberland Pharmaceuticals Inc. He oversees the company's strategic development and growth initiatives, playing a key role in optimizing operations and products.
